WASHINGTON. Aspirin, which is used in low dose, would reduce the severity of symptoms and differences in the immune system of patients with multiple sclerosis, after the effect is reduced in a mouse experiment.
This is according to a study published today in the magazine Science Signaling.
According to the research, aspirin oratory of laboratories expected the harshness of symptoms, the degradation of myelinus and increased the infiltration of cells in the spinal cord.
However, the amount of aspirin that was applied to the mouse was, however, also a dose of children's book # 39; medicine in human adults.
Multiple sclerosis is a degenerative disease that has more than 2.3 million people in the world and its origin is the loss of myelin, many of the nervous system that is responsible for the transfer of electrical impulses and the protection of neurons.
Researchers at Rush University (Chicago) discovered an unknown effect of this common drug, which is just used to leave pain.
With a small amount, aspirin could stimulate the production of positive cells for nervous transmission, while the activity of these mallic cells succeeds – Tregg – the nervous system attacks, mileage and are responsible for uncertainty causing cause the symptoms of multiple sclerosis.
The scientific team, led by Susanta Mondal, ensured that the safety of an active inhibition of aspirin and their administration morality, so it can be used as a supporting therapy for patients with multiple sclerosis and other car immunizations that relate to the disorder of the same Treg cells.